CVS Group (LON:CVSG) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Key Points

• CVS Group's price target was raised by Royal Bank of Canada from GBX 1,500 to GBX 1,900, indicating a potential upside of 34.34% from its current price.
• Several analysts, including Berenberg Bank and Peel Hunt, have issued "buy" ratings for CVS Group, with a consensus price target of GBX 1,800.
• The company's recent earnings report revealed an EPS of GBX 80.10, with expectations of 93.94 EPS for the current fiscal year.

CVS Group (LON:CVSG - Get Free Report) had its price target raised by research analysts at Royal Bank Of Canada from GBX 1,500 to GBX 1,900 in a research report issued on Tuesday, Marketbeat reports. The brokerage currently has an "outperform" rating on the stock. Royal Bank Of Canada's price target would indicate a potential upside of 34.34% from the stock's current price.

A number of other research firms also recently commented on CVSG. Berenberg Bank restated a "buy" rating and issued a GBX 2,000 price objective on shares of CVS Group in a report on Wednesday, October 15th. Peel Hunt restated a "buy" rating and issued a GBX 1,600 price objective on shares of CVS Group in a report on Tuesday, October 7th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat, CVS Group has a consensus rating of "Buy" and a consensus price target of GBX 1,800.

CVS Group Stock Performance

Shares of LON CVSG opened at GBX 1,414.29 on Tuesday. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. CVS Group has a one year low of GBX 791 and a one year high of GBX 1,648. The business's 50-day moving average price is GBX 1,269.39 and its two-hundred day moving average price is GBX 1,218.42. The company has a market capitalization of £1.01 billion, a P/E ratio of 372.18, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02.

CVS Group (LON:CVSG - Get Free Report) last released its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. Analysts anticipate that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

CVS Group Company Profile

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.